期刊
HUMAN MUTATION
卷 42, 期 10, 页码 1215-1220出版社
WILEY
DOI: 10.1002/humu.24252
关键词
epileptic encephalopathy; muscarinic receptor; whole-exome sequencing
资金
- Ministerio de Ciencia e Innovacion [RTI2018-093493-B-I00]
- Instituto de Salud Carlos III [PI15/01791]
- Institucio Catalana de Recerca i Estudis Avancats
De novo rare damaging variants in genes involved in critical developmental pathways have been identified in two unrelated patients with neurodevelopmental disorders, leading to reduction in protein levels and impaired cellular trafficking. These variants affect muscarinic signaling and intracellular pathways, potentially lowering seizure threshold and severely impairing neurodevelopment.
De novo rare damaging variants in genes involved in critical developmental pathways, notably regulation of synaptic transmission, have emerged as a frequent cause of neurodevelopmental disorders (NDD). NDD show great locus heterogeneity and for many of the associated genes, there is substantial phenotypic diversity, including epilepsy, intellectual disability, autism spectrum disorder, movement disorders, and combinations thereof. We report two unrelated patients, a young girl with early-onset refractory epilepsy, severe disability, and progressive cerebral and cerebellar atrophy, and a second girl with mild dysmorphism, global developmental delay, and moderate intellectual disability in whom trio-based whole-exome sequencing analysis uncovered de novo missense variants in CHRM1. Biochemical analyses of one of the NDD-associated variants proved that it caused a reduction in protein levels and impaired cellular trafficking. In addition, the mutated receptor showed defective activation of intracellular signaling pathways. Our data strengthen the concept that brain-reduced muscarinic signaling lowers the seizure threshold and severely impairs neurodevelopment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据